Cervical cancer after LACC trial…what do we do?

ESGO eAcademy, Faculty / Presenters, 347831

Professor Vergote and research & education

ESGO eAcademy, Nicole Concin, 347284

Professor Vergote and international collaborations

ESGO eAcademy, Andreas du Bois, 347282

35 years dedicated to Gynecological Oncology … and best yet to come

ESGO eAcademy, Andreas du Bois, 347280

Adherence to European ovarian cancer guidelines and impact on survival: a French multicenter study (FRANCOGYN)

ESGO eAcademy, Floriane Jochum, 347277

Masterclass in Gynaecological Oncology (2021)

ESGO eAcademy, Faculty / Presenters, 347291

Module 5: Miscellaneous | Assessment

ESGO eAcademy, Faculty / Presenters, 347290

Module 5: Miscellaneous

ESGO eAcademy, Faculty / Presenters, 347289

Module 4: Malignant tumours of the ovaries | Assessment

ESGO eAcademy, Faculty / Presenters, 347288

Module 4: Malignant tumours of the ovaries

ESGO eAcademy, Faculty / Presenters, 347287

Module 3: Malignant tumours of the uterus | Assessment

ESGO eAcademy, Faculty / Presenters, 347286

Module 3: Malignant tumours of the uterus

ESGO eAcademy, Faculty / Presenters, 347285

Module 2: Cervical cancer | Assessment

ESGO eAcademy, Faculty / Presenters, 347283

Module 2: Cervical cancer

ESGO eAcademy, Faculty / Presenters, 347281

Module 1: Vulvar cancer | Assessment

ESGO eAcademy, Faculty / Presenters, 347279

Module 1: Vulvar cancer

ESGO eAcademy, Faculty / Presenters, 347278

Implementation of robotic surgery in gyne-oncology and its impact on patient care. Experience from a 16 year journey - On Demand

ESGO eAcademy, Faculty / Presenters, 347256

Implementation of robotic surgery in gyne-oncology and its impact on patient care. Experience from a 16 year journey

ESGO eAcademy, Faculty / Presenter(s), 347255

Registration Form

ESGO eAcademy, Faculty / Presenters, 347253

Evaluation Form & Certificate

ESGO eAcademy, Faculty / Presenters, 346461

Telemedicine in teaching and training

ESGO eAcademy, Maja Pakiz, 341091

Teleradiology - a practical overview of currently available modalities

ESGO eAcademy, Fausto Labruto, 341090

Remote appointments via telemedicine - a patient's perspective

ESGO eAcademy, Victoria Clare, 341089

Discussion-Oral communication 4: Quality of Life and Patient Care

ESGO eAcademy, Faculty / Presenters, 343828

Self-management and adherence to recommended follow-up after gynaecological cancer: results from the international InCHARGE study

ESGO eAcademy, Ingvild Vistad, 343827

Patient-reported lower limb lymphedema and quality of life after radical surgery with sentinel node mapping for early-stage cervical cancer

ESGO eAcademy, Sara Sponholtz, 343825

Feasibility of a telemedicine lifestyle-based rehabilitation program (HEAL) for gynecological cancer patients

ESGO eAcademy, Nnamdi Gwacham, 343821

European multi-disciplinary tumour boards support cross-border networking and increase treatment options for patients with rare tumours

ESGO eAcademy, Ulrika Joneborg, 343819

Unmet needs-GCIG Consensus meeting

ESGO eAcademy, Iain McNeish, 343816

Future trial designs in ovarian cancer

ESGO eAcademy, Jean-Emmanuel Kurtz, 343815

Specific subgroups of ovarian cancer -GCIG consensus meeting

ESGO eAcademy, Gourley Charlie, 343814

Recurrent Ovarian Cancer -GCIG consensus meeting

ESGO eAcademy, Domenica Lorusso, 343813

Ovarian Cancer First-line treatment - GCIG Consensus Meeting

ESGO eAcademy, Antonio Gonzalez-Martin, 343812

How was consensus obtained in OCCC6?

ESGO eAcademy, Ignace Vergote, 343811

Tips and tricks of stoma closure - when and how

ESGO eAcademy, Martina Angeles, 341078

Ghost ileostomy (indications, technique, experience)

ESGO eAcademy, Victor Lago, 341077

Stoma placement techniques

ESGO eAcademy, Andrei Pletnev, 341075

Avelumab combined with pegylated liposomal doxorubicin in platinum-resistant/refractory ovarian cancer: biomarker analyses from JAVELIN Ovarian 200

ESGO eAcademy, Eric Pujade-Lauraine, 343808

The annual recurrence risk model for tailored surveillance strategy in cervical cancer patients

ESGO eAcademy, David Cibula, 343807

Partial molar pregnancy with a coexisting fetus; Case series and review of the literature

ESGO eAcademy, Leonora Coopmans, 343805

Impact of disease progression on health-related quality of life of advanced ovarian cancer (AOC) patients – pooled analysis from the PRIMA Trial

ESGO eAcademy, Dana Chase, 343804

Is the serous tubal intraepithelial carcinoma to blame for peritoneal carcinomatosis after risk-reducing salpingo-oophorectomy?

ESGO eAcademy, Miranda P. Steenbeek, 343803

Ovarian cancer onset across different BRCA mutation type

ESGO eAcademy, Claudia Marchetti, 343802

Lower-limb lymphedema after sentinel lymph node biopsy in cervical cancer patients

ESGO eAcademy, Renata Poncova, 343798

Frequency of pathogenic mutations and prognostic impact of germline gene panel testing in patients with primary epithelial ovarian cancer

ESGO eAcademy, Beyhan Ataseven, 343799

Incidence of lymph node metastasis in cervical carcinoma with ≤5 mm depth of invasion and >7 mm horizontal spread

ESGO eAcademy, Laure Nicolai, 343800

Can a cone biopsy predict nodal status in  early cervical cancer?

ESGO eAcademy, ENRIQUE CHACON, 343801

Screening in the era of HPV vaccination: what changes to expect

ESGO eAcademy, Peter David Sasieni Sasieni, 341064

Prophylactic HPV vaccination in women with previous cervical disease and global impact

ESGO eAcademy, Maria Kyrgiou, 341063

Combining targeted agents - Discussion

ESGO eAcademy, Faculty / Presenters, 343795

Combinatorial approaches in endometrial cancer

ESGO eAcademy, Domenica Lorusso, 343794

Combinations to reverse resistance to PARPi in ovarian cancer

ESGO eAcademy, Amit Oza, 343793

What is the best combinatorial partner to enhance benefit from PDL1i in cervical cancer?

ESGO eAcademy, Alexandra Leary, 343792

Non-epithelial vulvar malignancies and treatment options

ESGO eAcademy, Elena Ulrikh, 343790

New trends in the treatment of vulvar squamous cell cancer

ESGO eAcademy, Maaike Oonk, 343789

What is the best combinatorial partner to enhance benefit from PDL1i in cervical cancer?

ESGO eAcademy, Alexandra Leary, 350674

Prophylactic HPV vaccines: evidence and challenges

ESGO eAcademy, Elmar Joura, 341062

Presentation of the ESGO-ISUOG-IOTA-ESGE Consensus statement on preoperative diagnosis of ovarian masses

ESGO eAcademy, Christina Fotopoulou, 341052

Overview of staging imaging modalities and an assessment of tumour resectability

ESGO eAcademy, Daniela Fischerova, 341051

Glandular carcinoma of cervix

ESGO eAcademy, Marie Plante, 343785

Mullerian Adenosarcomas of the Female Genital Tract

ESGO eAcademy, Michael Friedlander, 343784

Papillary serous carcinoma of uterus

ESGO eAcademy, Bradley J. Monk, 343783

High grade endometrial and undifferentiated sarcoma

ESGO eAcademy, Patricia Pautier, 343782

Low grade endometrial stromal sarcoma

ESGO eAcademy, Frederic Amant, 343781

Carcinoid ovarian tumour

ESGO eAcademy, EVA GOMEZ GARCIA, 343780

Clear cell cervical and uterine carcinoma

ESGO eAcademy, Mary McCormack, 343779

Non squamous vulvar and vaginal carcinoma

ESGO eAcademy, Mario Leitao Jr., 343778

Borderline Ovarian Tumours

ESGO eAcademy, Christianne Lok, 343786

Overview of the diagnosis of ovarian masses

ESGO eAcademy, Dirk Timmerman, 341050

ONLINE Scientific session 3: ESGO-GCIG rare tumours project: Algorithms to guide management

ESGO eAcademy, Faculty / Presenters, 341042

Small Cell Carcinoma of the Cervix (SCCC)

ESGO eAcademy, Olesya Solheim, 343787

Financial toxicity of PARP inhibitor maintenance: a US and European perspective - Q&A

ESGO eAcademy, Faculty / Presenters, 341026

Inguino-femoral lymphadenectomy

ESGO eAcademy, Christina Pappa, 341039

Extra-peritoneal left pelvic lymphadenectomy

ESGO eAcademy, Agnieszka Rychlik, 341038

EU PARP financial toxicity

ESGO eAcademy, Richard Sullivan, 341025

Video abstract 2 - ID 640: Raising adequate vaginal margins during colpotomy for cervical cancer

ESGO eAcademy, Shylasree TS, 341037

Video abstract 1 - ID 357: Step by step laparoscopic hysterectomy with pelvic and para-aortic lymphadenectomy. Anatomical landmarks

ESGO eAcademy, Krzysztof Nowak, 341036

Laparoscopic ovarian transposition in 10 steps

ESGO eAcademy, Nicolò Bizzarri, 341035

The unique challenges of oral cancer therapy costs in gynecologic oncology: a perspective from the United States

ESGO eAcademy, Margaret Liang, 341024

Diagnostic accuracy of sentinel node biopsy in non-endometrioid, high-grade and/or deep myoinvasive endometrial cancer (TRSGO-SLN-006)

ESGO eAcademy, Duygu Altõn, 343772

Avelumab in patients with gestational trophoblastic tumors resistant to polychemotherapy: Efficacy outcomes of cohort B of TROPHIMMUN phase II trial.

ESGO eAcademy, Benoit You, 343771

Laparoscopic sentinel lymph node mapping - different techniques Tc, Blue, ICG and resection of parametrial lymphatic channel

ESGO eAcademy, Michael Halaska, 341034

Financial toxicity of gynecologic cancer treatment

ESGO eAcademy, Emeline Aviki, 341023

ONLINE Scientific session 2: Financial toxicity of PARP inhibitor maintenance: a US and European perspective

ESGO eAcademy, Faculty / Presenters, 341019